JERUSALEM, Feb. 25, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in March. Cowen 40th Annual Health Care ConferenceDate: March 2-5, 2020Company Presentation:&nb

SAN FRANCISCO, Feb. 25, 2020 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") announced today that it has entered into a license agreement with Artizan Biosciences, Inc. ("Artizan") for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support Artizan's antibody-based therapeutic discovery prog

SAN FRANCISCO, Feb. 25, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-foun

PARIS, Feb. 25, 2020 /PRNewswire/ -- This new beta DNA matching service allows everyone to upload the raw data of a DNA test kit taken from any company, and to compare it to other Geneanet members' DNA data for finding new relatives. Completely free of charge, Geneanet DNA supports DNA data from AncestryDNA, 23andMe, MyHeritage, Family Tree DNA and Living DNA. Two person

-"Building MOMENTUM for Patients with Myelofibrosis" scheduled for 10:00 a.m. ET on March 4, 2020 - VANCOUVER, Feb. 25, 2020 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and commercialization of momelotinib, a JAK1, JAK2 &am

CAMBRIDGE, England, Feb. 25, 2020 /PRNewswire/ -- Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bio's iPSC derived functional human cells widely available to the global life science community. Over the course of the next two years this new partnership will provide an increasing range of highly defined, sca

PITTSBURGH, Feb. 25, 2020 /PRNewswire/ -- With the release of Ansys® RaptorH™,

WALTHAM, Mass., Feb. 25, 2020 /PRNewswire/ -- Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreement with Moffitt Cancer Center. The collaboration will include genetically characterizing and classifying the mic

WALTHAM, Mass., Feb. 25, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its fourth quarter and year-end 2019 financial results on Tuesday, March 3, af

BOSTON, Feb. 25, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the mechanism of action of nesolicaftor (PTI-4